-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Pieris Pharmaceuticals, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q3 2013 to Q4 2019.
- Pieris Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2019 was $0.000.
- Pieris Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2019 was $0.000.
- Pieris Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
- Pieris Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
- Pieris Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000, a 100% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)